Australia's largest stock trading and investment forum Australia's #1 stock forum

KZA

Click for more information

0.00%

8.0¢ kazia therapeutics limited

Ann: Kazia announces change to Board of Directors, page-14

First 14 Last

Share
Profile

Follow
Gofish1

909 Posts.

101

11/08/23

12:28

Post #: 69288760
Share

Originally posted by bmfjch: ↑

Hi Slider,

I agree with you on the lack of reporting and transparency from Kazia, and sadly that seemingly has gotten worse recently. I think John needs to settle in, step up, be visible and provide regular investor updates. I hope to see him improve things soon.

However, I also think we need to acknowledge some of the pros and cons of the strategy of having 3rd party lead trials. Kazia has saved significant capital in having a large number of these trials run by world renowned researchers and medical institutions. The obvious problem is that Kazia loses control of the trials and the reporting to a large extent. This is on top of trying to manage the inherent issues with forecasting and the timely gathering, processing and reporting of trial data. Notwithstanding, I think Kazia could be significantly more transparent and timely with providing relevant updates and details to the market.

Expand

TO JG's credit he did put stuff out there. Did PR interviews etc, even if they didn't seem to get much traction.
Now there seems to be no communication strategy.

KZA Price at posting: 14.0¢ Sentiment: Hold Disclosure: Held
9 Upvote

3 Great analysis

Reply

Top Stories

BUX

Buxton projects new graphite province discovery at WA Narryer play

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

There are more pages in this discussion • 7 more messages in this thread...

First 14 Last

Add KZA (ASX) to my watchlist